A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

Running, not enrolling

Conditions studied: Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis

In brief

TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Key facts

Study ID

NCT03251118

Run by

Target PharmaSolutions, Inc.

People needed

15000

Starts

2017-07-24

Expected to finish

2027-03-01

Last updated by the study team

2026-03-17

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults and children (age 2 or older) with a diagnosis of Crohn's disease (CD), Ulcerative colitis (UC), or Indeterminate colitis (IBDU) having been prescribed any IBD treatment (initial or subsequent) outside of a clinical trial.
• Have plans for future visits at the site for continued management of IBD.

You may not qualify if…

• Inability to provide written informed consent/assent.
• Being enrolled in any interventional study or trial for IBD treatment. Note: Patient may be enrolled in other registries or studies where IBD treatment outcomes are observed and/or reported (such as center-based registries).
• Prior total abdominal colectomy for UC or IBDU.

Where it is running

• Om Research — Lancaster, California, United States
• FACEY Medical Foundation — Mission Hills, California, United States
• University of California - Davis — Sacramento, California, United States
• Stanford University — Stanford, California, United States
• University of Colorado Denver — Aurora, Colorado, United States
• Gastro Florida — Clearwater, Florida, United States
• University of Florida Health Jacksonville-Gastroenterology — Jacksonville, Florida, United States
• Advanced Gastroenterology Associates, LLC — Palm Harbor, Florida, United States
• Atlanta Gastro — Atlanta, Georgia, United States
• The University of Chicago Medical Center — Chicago, Illinois, United States
• Indianapolis Gastroenterology Research Foundation — Indianapolis, Indiana, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• Gastroenterology Associates — Baton Rouge, Louisiana, United States
• Louisiana Research Center, LLC — Shreveport, Louisiana, United States
• University of Michigan Medical Center — Ann Arbor, Michigan, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Saint Louis University — St Louis, Missouri, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
• Rutgers, Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
• NYU Langone Health — New York, New York, United States
• Mount Sinai, Icahn School of Medicine — New York, New York, United States
• Premier Medical Group of the Hudson Valley — Poughkeepsie, New York, United States
• The Children's Hospital at Montefiore — The Bronx, New York, United States
• Cary Gastroenterology Associates — Cary, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.